Cargando…

Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome

Nephrotic syndrome (NS) is a clinical syndrome resulting from abnormal glomerular permeability, mainly manifesting as edema and proteinuria. Qingrekasen granule (QRKSG), a Chinese Uyghur folk medicine, is a single-flavor preparation made from chicory (Cichorium intybus L.), widely used in treating d...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Yanfen, Zhang, Dongning, Ye, Yan, Zheng, Sili, Huang, Ping, Zhang, Fengyun, Mo, Guoyan, Huang, Fang, Yin, Qiang, Li, Jingjing, Han, Lintao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685401/
https://www.ncbi.nlm.nih.gov/pubmed/34938183
http://dx.doi.org/10.3389/fphar.2021.765563
_version_ 1784617827478536192
author Duan, Yanfen
Zhang, Dongning
Ye, Yan
Zheng, Sili
Huang, Ping
Zhang, Fengyun
Mo, Guoyan
Huang, Fang
Yin, Qiang
Li, Jingjing
Han, Lintao
author_facet Duan, Yanfen
Zhang, Dongning
Ye, Yan
Zheng, Sili
Huang, Ping
Zhang, Fengyun
Mo, Guoyan
Huang, Fang
Yin, Qiang
Li, Jingjing
Han, Lintao
author_sort Duan, Yanfen
collection PubMed
description Nephrotic syndrome (NS) is a clinical syndrome resulting from abnormal glomerular permeability, mainly manifesting as edema and proteinuria. Qingrekasen granule (QRKSG), a Chinese Uyghur folk medicine, is a single-flavor preparation made from chicory (Cichorium intybus L.), widely used in treating dysuria and edema. Chicory, the main component in QRKSG, effectively treats edema and protects kidneys. However, the active components in QRKSG and its underlying mechanism for treating NS remain unclear. This study explored the specific mechanism and composition of QRKSG on an NS rat model using integrated metabolomics and network pharmacology. First, metabolomics explored the relevant metabolic pathways impacted by QRKSG in the treatment of NS. Secondly, network pharmacology further explored the possible metabolite targets. Afterward, a comprehensive network was constructed using the results from the network pharmacology and metabolomics analysis. Finally, the interactions between the active components and targets were predicted by molecular docking, and the differential expression levels of the target protein were verified by Western blotting. The metabolomics results showed “D-Glutamine and D-glutamate metabolism” and “Alanine, aspartate, and glutamate metabolism” as the main targeted metabolic pathways for treating NS in rats. AKT1, BCL2L1, CASP3, and MTOR were the core QRKSG targets in the treatment of NS. Molecular docking revealed that these core targets have a strong affinity for flavonoids, terpenoids, and phenolic acids. Moreover, the expression levels of p-PI3K, p-AKT1, p-mTOR, and CASP3 in the QRKSG group significantly decreased, while BCL2L1 increased compared to the model group. These findings established the underlying mechanism of QRKSG, such as promoting autophagy and anti-apoptosis through the expression of AKT1, CASP3, BCL2L1, and mTOR to protect podocytes and maintain renal tubular function.
format Online
Article
Text
id pubmed-8685401
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86854012021-12-21 Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome Duan, Yanfen Zhang, Dongning Ye, Yan Zheng, Sili Huang, Ping Zhang, Fengyun Mo, Guoyan Huang, Fang Yin, Qiang Li, Jingjing Han, Lintao Front Pharmacol Pharmacology Nephrotic syndrome (NS) is a clinical syndrome resulting from abnormal glomerular permeability, mainly manifesting as edema and proteinuria. Qingrekasen granule (QRKSG), a Chinese Uyghur folk medicine, is a single-flavor preparation made from chicory (Cichorium intybus L.), widely used in treating dysuria and edema. Chicory, the main component in QRKSG, effectively treats edema and protects kidneys. However, the active components in QRKSG and its underlying mechanism for treating NS remain unclear. This study explored the specific mechanism and composition of QRKSG on an NS rat model using integrated metabolomics and network pharmacology. First, metabolomics explored the relevant metabolic pathways impacted by QRKSG in the treatment of NS. Secondly, network pharmacology further explored the possible metabolite targets. Afterward, a comprehensive network was constructed using the results from the network pharmacology and metabolomics analysis. Finally, the interactions between the active components and targets were predicted by molecular docking, and the differential expression levels of the target protein were verified by Western blotting. The metabolomics results showed “D-Glutamine and D-glutamate metabolism” and “Alanine, aspartate, and glutamate metabolism” as the main targeted metabolic pathways for treating NS in rats. AKT1, BCL2L1, CASP3, and MTOR were the core QRKSG targets in the treatment of NS. Molecular docking revealed that these core targets have a strong affinity for flavonoids, terpenoids, and phenolic acids. Moreover, the expression levels of p-PI3K, p-AKT1, p-mTOR, and CASP3 in the QRKSG group significantly decreased, while BCL2L1 increased compared to the model group. These findings established the underlying mechanism of QRKSG, such as promoting autophagy and anti-apoptosis through the expression of AKT1, CASP3, BCL2L1, and mTOR to protect podocytes and maintain renal tubular function. Frontiers Media S.A. 2021-12-06 /pmc/articles/PMC8685401/ /pubmed/34938183 http://dx.doi.org/10.3389/fphar.2021.765563 Text en Copyright © 2021 Duan, Zhang, Ye, Zheng, Huang, Zhang, Mo, Huang, Yin, Li and Han. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Duan, Yanfen
Zhang, Dongning
Ye, Yan
Zheng, Sili
Huang, Ping
Zhang, Fengyun
Mo, Guoyan
Huang, Fang
Yin, Qiang
Li, Jingjing
Han, Lintao
Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome
title Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome
title_full Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome
title_fullStr Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome
title_full_unstemmed Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome
title_short Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome
title_sort integrated metabolomics and network pharmacology to establish the action mechanism of qingrekasen granule for treating nephrotic syndrome
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685401/
https://www.ncbi.nlm.nih.gov/pubmed/34938183
http://dx.doi.org/10.3389/fphar.2021.765563
work_keys_str_mv AT duanyanfen integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome
AT zhangdongning integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome
AT yeyan integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome
AT zhengsili integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome
AT huangping integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome
AT zhangfengyun integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome
AT moguoyan integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome
AT huangfang integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome
AT yinqiang integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome
AT lijingjing integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome
AT hanlintao integratedmetabolomicsandnetworkpharmacologytoestablishtheactionmechanismofqingrekasengranulefortreatingnephroticsyndrome